Cancer Answer Line Stories
Treatment options for acute myeloid leukemia (AML) in seniors have remained stagnant for 40 years. We are participating in Beat AML, a research study focused on swift phenotyping and tailored therapies, with the ultimate goal of improving outcomes in this disease that otherwise becomes increasingly difficult to treat as patients age.
Breast cancer clinical trials are not experiments. Rather, they are options for women with breast cancer to receive the gold standard of cancer care paired with advanced therapies that can greatly improve their outcomes.
Should women stop using hormonal birth control because of a slightly increased risk of breast cancer? Dr. Bruce Carr says no. Discover how to weigh the risks and benefits of these contraceptives and others.
Learn how a breakthrough treatment trains children’s immune systems to fight back against leukemia.
Diagnosed at age 3 with a rare genetic disorder, Ryan Dant was not expected to live beyond age 10. But thanks to his parents who never lost hope and a clinical trial at UT Southwestern, the now 29-year-old recently finished college and is looking forward to life’s next chapter. “It’s an incredible story,” says UTSW’s Elizabeth Maher, M.D., Ph.D., one of the specialists on his team.
Not every kidney tumor needs treatment right away, if at all. Learn about active monitoring of early-stage kidney cancer and when we recommend it.
Prostate cancer is the second most common cancer in men. Use this guide to understand the risks, treatment options, and more.
A rare breast implant-related cancer was covered by the New York Times in spring 2017. Dr. Kenkel explains the symptoms and who is at risk.
Before she was diagnosed with Stage One breast cancer, Leslie LeBlanc was a busy working mom. Thanks to a new type of radiation therapy, she was able to get the treatment she needed without missing a beat.
This guide to cervical cancer will help women better understand this disease, know their risk, and learn the treatment options.